Afghanistan documents

Annual progress reports

All eligible countries are invited to submit proposals for Gavi support. 

Annual progress report Afghanistan 2003

Annual progress report Afghanistan 2002

Annual progress report Afghanistan 2001

Annual progress report Afghanistan 2014

Annual progress report Afghanistan 2013

Annual progress report Afghanistan 2012

Annual progress report Afghanistan 2011

Annual progress report Afghanistan 2010

Annual progress report Afghanistan 2009

Annual progress report Afghanistan 2008

Annual progress report Afghanistan 2007

Annual progress report Afghanistan 2006

Annual progress report Afghanistan 2005

Annual progress report Afghanistan 2004

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for CCEOP support 2019-2021: Afghanistan

Date of Gavi approval: 15 May 2019

Proposal for NVS-Measles follow up camp(2018-2020):Afghanisthan

Date of Gavi approval: 19 March 2018

Proposal for Rotavirus Support 2017: Afghanistan

Date of Gavi approval: 21 August 2017

Proposal for HSS Data Quality support 2016: Afghanistan

Date of Gavi approval: 17 June 2016

Proposal for HSS support 2015: Afghanistan

Date of Gavi approval: 09 December 2015

Proposal for NVS – IPV support

Date of Gavi approval: 30 June 2014

Proposal for NVS - Measles SIA support: Afghanistan

Date of Gavi approval: 12 May 2014

Proposal for NVS - PCV support: Afghanistan

Date of Gavi approval: 15 February 2013

Proposal for HSS support: Afghanistan

Date of Gavi approval: 30 July 2012

Proposal for CSO Type B support: Afghanistan

Date of Gavi approval: 17 July 2008

Proposal for NVS support: Afghanistan

Date of Gavi approval: 03 February 2008

Proposal for CSO Type A support: Afghanistan

Date of Gavi approval: 01 December 2007

Proposal for HSS funding: Afghanistan

Date of Gavi approval: 01 August 2007

Proposal for introduction of Hepatitis B Vaccine: Afghanistan

Date of Gavi approval: 01 November 2005

Proposal for NVS - Tetra support: Afghanistan

Date of Gavi approval: 01 November 2005

Proposal for ISS support: Afghanistan

Date of Gavi approval: 05 September 2002

Proposal for support: Afghanistan

Date of Gavi approval: 01 November 2000

Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Multi Year Plan of Action for EPI 2006-2010

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Co-financing information sheet Afghanistan

Co-financing of GAVI vaccines on the increase

Data quality audit

The DQA has been developed by WHO to help evaluate the quality of countries' health information systems and to verify the accuracy of reported data. Read more. 

DQA 2003

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

Decision-Letters-IPV-Afghanistan-2019.pdf

Decision Letter IPV Afghanistan 2021

Decision Letter Afghanistan IPV 2021

Decision Letter PCV Afghanistan 2020

Decision Letter PENTA Afghanistan 2020

Decision Letter RV Afghanistan 2020

Decision Letter HSS Afghanistan 2019

Decision Letter PCV Afghanistan 2019

Decision Letter PENTA Afghanistan 2019

Decision Letter RV Afghanistan 2019

Partnership Framework Agreement Afghanistan

Decision letter NVS Afghanistan 2013

Decision letter HSS Afghanistan 2012

Afghanistan Decision Letter CCEOP 2019

Decision Letter Afghanistan HSS 2019

Decision Letter NVS Afghanistan 2018

Decision Letter NVS Afghanistan 2017

Decision Letter NVS Afghanistan 2016 (2)

Decision Letter HSS Afghanistan 2016

Decision Letter NVS Afghanistan 2016

Decision Letter NVS Afghanistan 2015

Decision Letter NVS Afghanistan 2014(2)

Decision Letter NVS Afghanistan 2014

Decision letter NVS and HSS Afghanistan 2013

COVAX Technical Assistance Plans

In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.

COVAX Technical Assistance Plan Afghanistan 2021

Targeted country assistance plans

Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.

Targeted Country Assistance Plan Afghanistan 2021

Targeted Country Assistance Plan Afghanistan 2020

Targeted Country Assistance Plan Afghanistan 2019

Targeted country assistance plan Afghanistan 2018

Targeted country assistance plan Afghanistan 2017

The joint appraisal report and Multi-Stakeholder Dialogue

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.

Joint Appraisal Afghanistan 2019

Joint Appraisal Afghanistan 2017

Joint Appraisal Afghanistan 2018

Joint Appraisal Afghanistan 2016

Joint Appraisal Afghanistan 2015

Joint Appraisal Afghanistan 2014

Subscribe to our newsletter